LogiPharma 2022 Blog » News
Pharmaserv Logistics´ pharma distribution centre for storing, x-raying and packing pharmaceutical airfreight within Rhine-Main has opened in 06/2020.
After receiving authorisation from the US Food and Drug Administration (FDA) for Emergency Use of its single-shot vaccine against COVID-19, Johnson & Johnson is now facing up to the logistical challenges of making good on its promise to deliver 100 million doses of the drug to patients in the US during the first half of 2021.
The Pfizer-BioNTech COVID-19 vaccine has been authorised for the prevention of the virus in individuals aged 16 and above, by the US Food and Drug Administration (FDA), under an Emergency Use Authorisation (EUA). More broadly, there remains a huge demand for the Pfizer treatment and other COVID-19 drugs in poorer and more remote parts of the world, where temperature control becomes difficult.